These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 23708210)

  • 1. Adapting clinical paradigms to the challenges of cancer clonal evolution.
    Murugaesu N; Chew SK; Swanton C
    Am J Pathol; 2013 Jun; 182(6):1962-71. PubMed ID: 23708210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumor diversity and clonal evolution in cancer--a skeptical standpoint.
    Gisselsson D
    Adv Cancer Res; 2011; 112():1-9. PubMed ID: 21925299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic analysis of tumor clonality.
    Teixeira MR; Heim S
    Adv Cancer Res; 2011; 112():127-49. PubMed ID: 21925303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment.
    Apostoli AJ; Ailles L
    Crit Rev Clin Lab Sci; 2016; 53(1):40-51. PubMed ID: 26397062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-Evaluating Clonal Dominance in Cancer Evolution.
    Burrell RA; Swanton C
    Trends Cancer; 2016 May; 2(5):263-276. PubMed ID: 28741512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal evolution models of tumor heterogeneity.
    Shlush LI; Hershkovitz D
    Am Soc Clin Oncol Educ Book; 2015; ():e662-5. PubMed ID: 25993239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development.
    Dzobo K; Senthebane DA; Thomford NE; Rowe A; Dandara C; Parker MI
    OMICS; 2018 Jan; 22(1):17-34. PubMed ID: 29356626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenges of tumor genetic diversity.
    Mroz EA; Rocco JW
    Cancer; 2017 May; 123(6):917-927. PubMed ID: 27861749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapies of solid cancers: new options, new challenges.
    Awada A; Aftimos PG
    Curr Opin Oncol; 2013 May; 25(3):296-304. PubMed ID: 23493191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumor heterogeneity: nature and biological significance.
    Gerashchenko TS; Denisov EV; Litviakov NV; Zavyalova MV; Vtorushin SV; Tsyganov MM; Perelmuter VM; Cherdyntseva NV
    Biochemistry (Mosc); 2013 Nov; 78(11):1201-15. PubMed ID: 24460935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The origins of cancer robustness and evolvability.
    Tian T; Olson S; Whitacre JM; Harding A
    Integr Biol (Camb); 2011 Jan; 3(1):17-30. PubMed ID: 20944865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine.
    Hiley C; de Bruin EC; McGranahan N; Swanton C
    Genome Biol; 2014 Aug; 15(8):453. PubMed ID: 25222836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumor heterogeneity: origins, clinical significance and optimal strategies for cancer treatment.
    Mangano A; Lianos GD; Mangano A; Boni L; Dionigi G
    Future Oncol; 2015; 11(4):561-4. PubMed ID: 25686113
    [No Abstract]   [Full Text] [Related]  

  • 14. Clonal evolution in cancer.
    Greaves M; Maley CC
    Nature; 2012 Jan; 481(7381):306-13. PubMed ID: 22258609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumor heterogeneity in epigenetic patterns.
    Assenov Y; Brocks D; Gerhäuser C
    Semin Cancer Biol; 2018 Aug; 51():12-21. PubMed ID: 29366906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concerns about targeting cancer stem cell for cancer therapy.
    Yang G; Lu X; Fu H; Jin L; Yao L; Lu Z
    Med Hypotheses; 2011 Mar; 76(3):457. PubMed ID: 21288650
    [No Abstract]   [Full Text] [Related]  

  • 17. Deciphering intratumor heterogeneity using cancer genome analysis.
    Ryu D; Joung JG; Kim NK; Kim KT; Park WY
    Hum Genet; 2016 Jun; 135(6):635-42. PubMed ID: 27126234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenge of intratumour heterogeneity in precision medicine.
    Seoane J; De Mattos-Arruda L
    J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells with genetic instability: the best vehicle with the best engine for cancer.
    Lagasse E
    Gene Ther; 2008 Jan; 15(2):136-42. PubMed ID: 17989699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution.
    Gupta RG; Somer RA
    Mol Cancer Res; 2017 Sep; 15(9):1127-1137. PubMed ID: 28596419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.